When cardiomyocytes are under pathological condition, leading to heart failure, the expression levels of these three transporters are affected through most probably phosphorylation/activation of PKCα, consequently, [Zn2+]i is increased in cardiomyocytes. Here, PRKCA is linked to heart failure.